International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.

IF 2.6 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM Hormone Research in Paediatrics Pub Date : 2024-12-19 DOI:10.1159/000543266
Martin de Bock, Juliana Chizo Agwu, Matt Deabreu, Klemen Dovc, David M Maahs, M Loredana Marcovecchio, Farid H Mahmud, Yeray Nóvoa-Medina, Leena Priyambada, Carmel E Smart, Linda A DiMeglio
{"title":"International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets.","authors":"Martin de Bock, Juliana Chizo Agwu, Matt Deabreu, Klemen Dovc, David M Maahs, M Loredana Marcovecchio, Farid H Mahmud, Yeray Nóvoa-Medina, Leena Priyambada, Carmel E Smart, Linda A DiMeglio","doi":"10.1159/000543266","DOIUrl":null,"url":null,"abstract":"<p><p>The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol).</p>","PeriodicalId":13025,"journal":{"name":"Hormone Research in Paediatrics","volume":" ","pages":"650-658"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormone Research in Paediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000543266","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

The International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of ≤6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is ≤7.0% (53 mmol/mol).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
ISPAD临床实践共识指南2024:血糖目标。
新内容或不同之处 1.本章建议,对于能够使用连续血糖监测(CGM)和胰岛素自动给药(AID)等先进糖尿病技术的患者,HbA1c 的目标值为 ≤6.5% (48mmol/mol)。在可以安全达到这一目标的情况下,应鼓励所有儿童和青少年糖尿病患者达到这一目标。在其他情况下,HbA1c 目标值为 ≤7.0% (53mmol/mol)。强调较低的 HbA1c 目标是经过深思熟虑的,因为越来越多的证据表明,将 HbA1c 水平降至先前的目标值以下可显著降低患糖尿病并发症的风险,而且在有足够的技术和医护人员支持的情况下,这些较低的血糖目标可以安全地实现,而不会增加低血糖的风险或增加护理负担。2.2. 这些血糖目标可根据对糖尿病患者及其护理人员潜在挑战的评估进行个性化。3.3. 讨论血糖目标与体重超标率之间的关系。4.4. 与之前的版本相比,血糖目标章节更加简洁。本章旨在提供关于总体血糖管理的最新指导,以及其他提供进一步背景和信息的 ISPAD 共识指南,包括特定人群(如学龄前儿童、有限的护理环境)或情况(如运动)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hormone Research in Paediatrics
Hormone Research in Paediatrics ENDOCRINOLOGY & METABOLISM-PEDIATRICS
CiteScore
4.90
自引率
6.20%
发文量
88
审稿时长
4-8 weeks
期刊介绍: The mission of ''Hormone Research in Paediatrics'' is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini reviews, clinical guidelines and papers on novel insights from clinical practice. Periodic editorials from outstanding paediatric endocrinologists address the main published novelties by critically reviewing the major strengths and weaknesses of the studies.
期刊最新文献
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring. International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes. New features in a rare monogenic obesity: CPE DEFICIENCY. Real-World Safety and Effectiveness of Vosoritide in Children with Achondroplasia: French Early Access Program. Automated Insulin Delivery Systems for treatment of type 1 diabetes: Strategies for Optimal Performance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1